2Heil G;Krauter J;Bergmann L.Risk adapted in ductron and sonsolida-tion therapy inleuding peripheral bloodstem cell trandplantation inadudt donovo AML patients,1998.
3Taksin A L;Thomas X;Castaigne S;etal.Limits for intensify induction therapyin youngerpatients with acite myeloge-nous leukemia,1998.
4Stasi R;Venditti A;Poeta G D.High-dose diemotherapy in adult acutemyeloid leukemia:Ralionale and results[J],1996.
5Elonen E;Almqvist A;Hanninen A;etal.Long term follow up of adultspatieats with acute myeloid leukemia re-sults of arandomized trial belweien 4and 8 cycles of chemotherapy,1998.
6CHEN Z X;Xue Y Q;Zhaong R.Aclinical and experimental study on all-trans retinoic acid-treated a cute promyelocytic Leukemia patients,1991.
7Bassan R.Randomized clinical trials in alult lymphoblastic leukemia: which is the question,1998.
8Archimbaund E;Fenanx P;Dombret H.GM-CSF increase efficacy of se-quential chemstherapy of a mnticenter tandomized trial,1998.
9Feldman E J;Alberts D S;Arlin Z.Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantronl in combination with cytarabine in patient with acute leukemia,1993.
10Damiani D;Midieli M;Emacora A.Adjuvent treatment with cyclosprin A increasethe toxicity of chemotherapy for romission induction in acute non-lymphocytic leukemia[J],1998.
